NASDAQ · Health Information Services · USD
DarioHealth Corp. (DRIO) Stock Analysis
DarioHealth Corp. (DRIO) is a Health Information Services stock listed on NASDAQ and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
DRIO Key Statistics
As of Oct 21, 2026Trading
- Open
- $4.10
- Previous Close
- $4.08
- Day's Range
- 3.13–4.20
- 52-Week Range
- 3.13–16.45
- Volume
- 266.18K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 1.18
Valuation
- Market Cap
- $36.06M
- P/E Ratio
- unprofitable
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 1.72
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −2.28
Financials (FY)
- Revenue (FY)
- $22.36M−17.31%
- Net Income (FY)
- −$41.71M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- −169.87%
- Shares Outstanding
- 9.80M
- 1-Year Return
- −74.48%
Dividend and dates
- Earnings Date
- November 12, 2026estimated
- Avg Volume
- 27.46K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, DRIO closed at $3.68, −74.48% over 1 year.
DarioHealth Corp. (DRIO) has a market capitalization of $36.06M.
In fiscal 2025, DRIO reported revenue of $22.36M.
DRIO Stock Return by Calendar Year
DarioHealth Corp. (DRIO) 10-year return: what $10,000 became
- 1 year
- $10,000 $2,552
- −74.48%
- 5 years
- $10,000 $114
- −98.86%
- 10 years
- $10,000 $532
- −94.68%
If you had invested $10,000 in DarioHealth Corp. (DRIO) 10 years ago, at the close on October 21, 2016, it would have been worth $532 at the close on October 21, 2026: −94.68% in total, −25.43% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −67.66% |
| 2025 | −27.61% |
| 2024 | −54.30% |
| 2023 | −59.81% |
| 2022 | −67.00% |
| 2021 | −9.24% |
| 2020 | +117.84% |
| 2019 | +745.36% |
| 2018 | −51.56% |
| 2017 | −50.71% |
| 2016 (partial year) | −18.95% |
As of October 21, 2026.
DRIO Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $22.36M | −$41.71M | −186.6% |
| 2024 | $27.04M | −$42.75M | −158.1% |
| 2023 | $20.35M | −$59.43M | −292.0% |
| 2022 | $27.66M | −$62.19M | −224.9% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $22.36M | $12.67M | −$36.66M | −$41.71M | −186.6% |
| 2024 | $27.04M | $13.27M | −$57.74M | −$42.75M | −158.1% |
| 2023 | $20.35M | $5.98M | −$56.19M | −$59.43M | −292.0% |
| 2022 | $27.66M | $9.66M | −$56.81M | −$62.19M | −224.9% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
DRIO Valuation vs Health Information Services Median
Median of 44 stocks| Metric | DRIO | Health Information Services median | vs median |
|---|---|---|---|
| P/S ratio | 1.72 | 2.31 | 26% below |
| Profit margin | −169.87% | −7.55% | 162.3 pts below |
Medians across 44 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
DarioHealth Announces Independent Aon Analysis that Supports Estimated 2.5%-7.2% In-Year Reduction in Total Healthcare Costs
YahooDarioHealth Secures New Jersey Health Plan Contract Through Amwell Partnership; Dario's Cardiometabolic Suite Launch Set For Q1 2027
BenzingaAlliance Global Partners Initiates Coverage On DarioHealth with Buy Rating, Announces Price Target of $12
BenzingaTD Cowen Maintains Hold on DarioHealth, Lowers Price Target to $8
BenzingaDarioHealth (DRIO) Q2 2026 Earnings Call Transcript
The Motley FoolDarioHealth Corp (DRIO) (Q2 2026) Earnings Call Highlights: Multi-Condition Platform Drives ...
Yahoo
All 13 articles ↓Show fewer ↑
DarioHealth Corp. Q2 2026 Earnings Call Summary
MobyDarioHealth Q2 Earnings Call Highlights
MarketBeatDarioHealth Corp. (DRIO) Reports Q2 Loss, Lags Revenue Estimates
YahooDarioHealth Corp. (DRIO) Q2 2026 Earnings Call Transcript
SeekingAlphaDarioHealth Reports Second Quarter 2026 Financial Results
YahooDarioHealth Q2 Adj. EPS $(0.72) Beats $(1.22) Estimate, Sales $5.177M Miss $5.923M Estimate
BenzingaDarioHealth Launches GLP-1 Program, With Commercial Availability Expected Fall 2026, With Revenue Contribution From Late 2026 And Ramping Through 2027
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Health Information Services Stocks
Veeva Systems Inc.
$51.90B
BTSGBrightSpring Health Services, Inc.
$12.40B
TEMTempus AI, Inc.
$12.23B
HNGEHinge Health, Inc.
$9.04B
HQYHealthEquity, Inc.
$8.10B
DOCSDoximity, Inc.
$5.99B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B








